Manufacturer: GlaxoSmithKline
Active Ingredients: FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
FDA Approval: August 24, 2000
Manufacturer: GlaxoSmithKline
Active Ingredients: FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
FDA Approval: June 8, 2006
Manufacturer: Sepracor
Active Ingredients: ARFORMOTEROL TARTRATE
FDA Approval: October 6, 2006
Manufacturer: Novartis
Active Ingredients: FORMOTEROL FUMARATE
FDA Approval: February 16, 2001
Manufacturer: Dey LP
Active Ingredients: FORMOTEROL FUMARATE
FDA Approval: May 11, 2007
Manufacturer: Glaxo Grp LTD
Active Ingredients: SALMETEROL XINAFOATE
FDA Approval: September 19, 1997
Manufacturer: Astrazeneca
Active Ingredients: BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
FDA Approval: July 21, 2006
If you or a loved one suffered from a long-acting beta-agonist like the ones mentioned on this page, please contact us today for a free legal consultation. Call Mark & Associates, P.C. at 1-866-50-RIGHTS (1-866-507-4448) or, alternatively, fill out our web form and someone will contact you.
Click to Call Our Team Immediately Toll Free
Questions? Click Here to Speak to Us
Contact us today for an immediate and confidential review of your case.
Copyright ©2012 Mark & Associates, P.C. | All Rights Reserved | ATTORNEY ADVERTISING
Prior Results Do Not Guarantee a Similar Outcome.
Mark & Associates, P.C. maintains offices in Massachusetts and New York, and works with attorneys throughout the country.
Please note that, by contacting Mark & Associates, P.C., your potential case may be referred to an attorney within our nationwide network.
Dangerous drug lawyers.